UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------
FORM 8-K
------------
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
July 15, 2003
USANA HEALTH SCIENCES, INC.
(Exact name of registrant as specified in its charter)
Commission File No. 0-21116
Utah 87-0500306
(State or other jurisdiction of (IRS Employer Identification
incorporation) Number)
3838 West Parkway Boulevard
Salt Lake City, Utah 84120
(Address of principal executive offices, Zip Code)
Registrant's telephone number, including area code: (801) 954-7100
Former name or former address, if changed since last report: Not Applicable
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits
99.1 Press release issued by USANA Health Sciences, Inc. dated July 15, 2003
99.2 Transcript from the conference call held by USANA Health Sciences, Inc. on
July 16, 2003
Item 12. Results of Operations and Financial Condition
On July 15, 2003, USANA Health Sciences, Inc. issued a press release announcing
its financial results for the second quarter ended June 28, 2003. On July 16,
2003, USANA Health Sciences, Inc. held a conference call to announce and discuss
its financial results with institutional investors for the second quarter ended
June 28, 2003. Copies of the press release and the conference call transcript
are furnished herewith as Exhibit 99.1 and Exhibit 99.2, respectively to this
form 8-K and are incorporated herein by reference. The company will also post
these documents on its corporate website, www.usanahealthsciences.com under the
"investor relations" link.
The information in this Current Report is being furnished and shall not be
deemed "filed" for the purposes of Section 18 of the Securities and Exchange Act
of 1934, as amended, or otherwise subject to the liabilities of that Section.
The information in this Current Report shall not be incorporated by reference
into any registration statement or other document pursuant to the Securities Act
of 1933, as amended. The furnishing of the information in this Current Report is
not intended to, and does not, constitute a representation that such furnishing
is required by Regulation FD or that the information this Current Report
contains is material investor information that is not otherwise publicly
available.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
USANA HEALTH SCIENCES, INC.
By: /s/ Gilbert A. Fuller
---------------------
Gilbert A. Fuller,
Chief Financial Officer
Date: July 17, 2003